MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

MindWalk Holdings Corp.NASDAQ: HYFT

Revenue · Q3 FY2026 · quarter ended Jan 2026

Revenue dips below year-ago levels

Q3 FY2026 revenue of CA$4.09M fell 33.5% year over year, behind the +3.3% change in trailing-twelve-month revenue. Sequentially, it fell 0.8% from the prior quarter. Over 3 fiscal years it compounded at +8.2% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 2 analysts of CA$15.87M (-35.3%) for the fiscal year ending Apr 2026, a slowdown from the +0.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJan 2026
CA$4.09M-0.8% QoQ
Last fiscal yearApr 2025
CA$24.52M+0.0% YoY
LTMJan 2026
CA$18.36M+3.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-33.5%-36.8%-3.3 pp
1 year+0.0%-35.3%-35.3 pp
3-year CAGR+8.2%-4.2%-12.3 pp
5-year CAGR+6.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CAD · from the income statement

Latest · FY2025
24.52M CAD
Year-over-year change
+0.0%
4-year CAGR
+8.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +3.3% is the 4th highest of 6, against a peer median of +14.5%.
  • Over three fiscal years its annual growth of +8.2% compares with a peer median of -24.9%.
HYFT Competitors
Revenue for HYFT and competitors
Company Period LTM YoY 3-year CAGR
FBIOFortress Biotech, Inc.LTM Mar 2026$66.16M USD+14.5%-5.8%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$18.36M CAD+3.3%+8.2%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$3.93M USD+160.5%—
ATYRaTyr Pharma, Inc.LTM Mar 2026$190K USD—-73.7%
CLNNClene Inc.LTM Mar 2026$134K USD-61.7%-24.9%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$0 USD——
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$0 USD——
BYSIBeyondSpring Inc.LTM Mar 2026$0 USD+100.0%—
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD-100.0%—
Peer median (excluding HYFT) —+14.5%-24.9%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue17.91M19.36M20.67M24.52M24.52M
Cost of Revenue6.37M8.38M9.1M12.47M10.97M
Gross Profit11.54M10.98M11.56M12.05M13.55M
Gross Margin64.4%56.7%56.0%49.2%55.3%
Research & Development1.97M7.66M14.1M4.04M4.94M
Selling, General & Admin13.27M18.06M18.99M19.14M19.03M
Operating Expenses15.71M27.66M37.17M25.82M25.74M
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
EBITDA(1.42M)(11.99M)(21.04M)(22.95M)(28.86M)
EBITDA Margin-7.9%-61.9%-101.8%-93.6%-117.7%
Operating Income(4.18M)(16.67M)(25.61M)(13.76M)(12.2M)
Operating Margin-23.3%-86.1%-123.9%-56.1%-49.7%
Interest Income265.01K279K122K23K0
Interest Expense602.37K85K30K19K9.91K
Other Income / Expenses(1.82M)825K(2.14M)(14.94M)(22.07M)
Income Before Tax(6M)(15.85M)(27.75M)(28.7M)(34.27M)
Pre-Tax Margin-33.5%-81.8%-134.3%-117.1%-139.8%
Income Tax Expense1.35M861K(1.19M)(2.59M)(4.03M)
Net Income(7.34M)(16.71M)(26.56M)(26.12M)(30.23M)
Net Margin-41.0%-86.3%-128.5%-106.5%-123.3%
EPS (Basic)(0.45)(0.87)(1.07)(1.03)(0.90)
EPS (Diluted)(0.45)(0.87)(1.07)(1.03)(0.90)
Weighted Avg Shares16.47M19.69M24.9M25.64M33.39M
Weighted Avg Shares (Diluted)16.47M19.69M24.9M25.64M33.39M

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.